- 专利标题： COMPOUNDS FOR TARGETED DEGRADATION OF RET
-
申请号： US18105735申请日： 2023-02-03
-
公开(公告)号： US20230233692A1公开(公告)日： 2023-07-27
- 发明人: James A. Henderson , Christopher G. Naveschuk , Kiel Lazarski , Victoria Garza , Moses Moustakim , Jae Young Ahn , Gesine Kerstin Veits , Morgan Welzel O'Shea , Ryan E. Michael , Jeremy L. Yap , Yanke Liang , Andrew Charles Good , Mark E. Fitzgerald , Robert T. Yu
- 申请人： C4 Therapeutics, Inc.
- 申请人地址： US MA Watertown
- 专利权人： C4 Therapeutics, Inc.
- 当前专利权人： C4 Therapeutics, Inc.
- 当前专利权人地址： US MA Watertown
- 主分类号： A61K47/55
- IPC分类号： A61K47/55
摘要：
Novel compounds which act as protein degradation inducing moieties for proto-oncogene tyrosine-protein kinase receptor (RET), which may be either wild type RET or a mutant form of RET.
信息查询
IPC分类:
